Drawing based on the label description. No photo yet.
“The tablets are white, capsule shaped, film coated and debossed with "GSI" on both sides”
GSI pill
Pill with imprint GSI is white, capsule, 19 mm and has been identified as Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil Fumarate 200 mg / 25 mg / 300 mg. It is used for HIV. It is supplied by Gilead Sciences, Inc.
Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil Fumarate 200 mg / 25 mg / 300 mg
- Imprint
- GSI
- Strength
- Emtricitabine 200 mg / Rilpivirine 25 mg / Tenofovir Disoproxil Fumarate 300 mg
- Used for
- HIV
- Color
- White
- Shape
- Capsule / oblong
- Size
- 19 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Gilead Sciences, Inc
- Drug class
- HIV medicine
- NDC
- 61958-1102, 61958-1102-5
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
All Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil Fumarate pills and guides
What is Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil Fumarate used for?
Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil Fumarate is used for HIV.
- Medicine type
- HIV medicine
Official uses from the US prescribing label
COMPLERA™ is indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg:
- as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies/mL at the start of therapy or
- to replace a stable antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen for at least 6 months with no treatment failure and no known substitutions associated with resistance to the individual components of COMPLERA.
Limitations of Use:
- More rilpivirine-treated subjects with HIV-1 RNA greater than 100,000 copies/mL at the start of therapy experienced virologic failure (HIV-1 RNA ≥50 copies/mL) compared to rilpivirine-treated subjects with HIV-1 RNA less than or equal to 100,000 copies/mL.
From the FDA-approved label on DailyMed (published Jul 25, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows GSI.
- It is white, capsule, 19 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Complera Access.
Ingredients
Active: Emtricitabine, Rilpivirine Hydrochloride, Tenofovir Disoproxil Fumarate
Inactive: Microcrystalline Cellulose, Lactose Monohydrate, Povidone, Unspecified, Polysorbate 20, Croscarmellose Sodium, Magnesium Stearate, Starch, Corn, Hypromellose, Unspecified, Titanium Dioxide, Triacetin, Water
Other pills with imprint GSI
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AC 79
Theophylline 450 mg
White, capsule, 19 mm
Used for asthma
-
270 80
Atomoxetine 80 mg
Brown & white, capsule, 19 mm
Used for ADHD
-
266 18
Atomoxetine 18 mg
White & yellow, capsule, 19 mm
Used for ADHD
-
265 10
Atomoxetine 10 mg
White, capsule, 19 mm
Used for ADHD
-
par 727
Doxycycline 100 mg
Brown & white, capsule, 19 mm
Used for pneumonia and syphilis
-
IPX203 210
Carbidopa and Levodopa 52.5 mg / 210 mg
Green & white, capsule, 20 mm
Used for Parkinson's disease